Status:

UNKNOWN

Secondary Prevention By Structured Semi-Interactive Stroke Prevention Package in INDIA (SPRINT INDIA) Study

Lead Sponsor:

Christian Medical College and Hospital, Ludhiana, India

Collaborating Sponsors:

Indian Council of Medical Research

Conditions:

Stroke

Eligibility:

All Genders

18-99 years

Phase:

NA

Brief Summary

Recurrent stroke, cardiovascular morbidity and mortality are important causes of poor outcome in patients with index stroke. According to the INTERSTROKE study, 80% of stroke are preventable due to th...

Detailed Description

Stroke is the second leading cause of death worldwide in 2010. In rural Maharashtra, it is the leading cause of death. The Stroke incidence in India ranges from 135 to 145 per 100,000 population. From...

Eligibility Criteria

Inclusion

  • Age 18 years and above including both men and women
  • First-ever Ischemic stroke or intracerebral haemorrhage
  • Between 2 days-3 months of stroke symptom onset
  • Computed Tomography /Magnetic Resonance Imaging shows recent stroke (infarct and/or hemorrhage)
  • Able to read and complete simple tasks suggested in the stroke workbook if having aphasia or is illiterate, a caregiver is available to read for the patients and complete the reading/workbook tasks for the patients.
  • Able to read and possess a working personal mobile cellular device. In case of patients who is not able to read and/or don't have a personal mobile cellular device or unable to use it, a caregiver is available all times who is able to use mobile cellular devices and read to the patient.
  • Able to watch health education videos on a video player on cellular device or any other video player available to the patient.
  • Able to come for follow up visits for at least 1 year
  • Able to provide signed informed consent.

Exclusion

  • Modified Rankin scale score 0 and 1 at the time of enrollment
  • Limited internet and/or mobile accessibility due to travel
  • Patients having active malignancies needing intensive therapy
  • Patients with a terminal illness with an anticipated lifespan of less than 1 year
  • Patients with heart failure admitted more than twice in the last six months
  • Patients with current psychiatric illness with loss of insight and suicide attempts
  • Patients with cerebral venous sinus thrombosis, aneurysmal subarachnoid haemorrhage, isolated central nervous system vasculitis and systemic vasculitis

Key Trial Info

Start Date :

April 28 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 30 2022

Estimated Enrollment :

5830 Patients enrolled

Trial Details

Trial ID

NCT03228979

Start Date

April 28 2018

End Date

March 30 2022

Last Update

July 28 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Christian Medical College and Hospital

Ludhiana, Punjab, India, 141008